JACOBS LEVY EQUITY MANAGEMENT, INC

Position in LNTH — Lantheus Holdings, Inc.

CIK 884414 FLORHAM PARK, NJ

Back to LNTH Full portfolio

Position in LNTH

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$77,611,738

+$33,797,365 QoQ

Shares Held

699,583

+21.1% QoQ

Ownership

1.07%

of shares outstanding

% of Portfolio

0.28%

of 13F equity value

Holder Rank

#25

of 466 holders

Holding Since

Mar 2020

9 quarters on record

Voting authority Sole 79% Shared 0% None 21%

Common Shares in LNTH Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

JACOBS LEVY EQUITY MANAGEMENT, INC holds $311,064,443 across 17 Drug Manufacturers - Specialty & Generic names. LNTH ranks #2 (25.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc	726,112	$122,378,916
2	LNTH	Lantheus Holdings, Inc. This page	699,583	$77,611,738
3	ZTS	Zoetis Inc.	579,079	$41,612,616
4	LQDA	Liquidia Corp	240,752	$19,195,156
5	IRWD	Ironwood Pharmaceuticals Inc	4,065,964	$17,117,708
6	BIOA	BioAge Labs, Inc.	377,085	$9,242,353
7	PCRX	Pacira BioSciences, Inc.	199,800	$5,068,926
8	AKBA	Akebia Therapeutics, Inc.	4,273,026	$4,871,249

All Filings in LNTH

Export CSV

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$77,611,738	699,583	+21.1%	Shares	Sole	2026-08-14
2026-03-31	$43,814,373	577,645	+216.9%	Shares	Sole	2026-05-15
2025-12-31	$12,132,397	182,305	+33.1%	Shares	Sole	2026-02-13
2025-09-30	$7,022,831	136,924	+409.0%	Shares	Sole	2025-11-17
2024-12-31	$2,406,474	26,900	-25.4%	Shares	Sole	2025-02-14
2020-12-31	$486,624	36,073	-40.0%	Shares	Sole	2021-02-16
2020-09-30	$761,682	60,117	-40.1%	Shares	Sole	2020-11-16
2020-06-30	$1,434,862	100,340	+314.7%	Shares	Sole	2020-08-17
2020-03-31	$308,702	24,193	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.